Skip to main content
. 2021 Aug 1;17(8):1685–1694. doi: 10.5664/jcsm.9404

Table 3.

Efficacy results.

Endpoint NPNS Sham P
IRLS .003*
 Baseline, SD 24.0 24.0
 During treatment, SD 17.2 20.6
 Mean change (SEM) –6.81 (0.94) –3.38 (0.96)
CGI-I
 Responder rate 66% 17% .001*
Daily NRS
 Before 4.25 4.39
 During (% change) 3.43 (–19.5%) 3.92 (–10.9%) .010*
 After (% change) 2.96 (–52.5%) 4.47 (+1.9%) .003*
Summary NRS
 Before 3.59 3.47
 During (% change) 2.50 (–30.3%) 2.85 (–17.8%) .088
 After (% change) 1.91 (–46.7%) 3.35 (–3.4%) .002*

P values denote comparisons between NPNS and sham and (*) denotes statistical significance at P < .05; 2-tailed matched-pairs t tests were used for IRLS, Daily NRS, and Summary NRS and a continuity-corrected paired proportions McNemar’s test was used for CGI-I. Values compared with statistical tests are in bold. Mean change in IRLS during NPNS and sham is relative to baseline (study entry) and % change to Daily and Summary NRS is relative to the “Before” time-point. CGI-I = Clinical Global Impressions-Improvement, IRLS = International RLS Study Group rating scale, NPNS = noninvasive peripheral nerve stimulation, NRS = Numerical Rating Scale, SD = standard deviation, SEM = standard error of the mean.